Achyranthes Aspera Root Extract Attenuates the Damage Caused by High Fat Diet and Streptozotocin-Induced Diabetes in Wistar Rats

Life Sciences -Anatomy

Authors

  • B. Shahajeer Tutor Dept. of Anatomy, Govt. Medical College Anantapur, Andhra Pradesh, PhD scholar Saveetha University Chennai. India https://orcid.org/0000-0002-9186-8416
  • Dr. Gunapriya Raghunathn Professor & Head of the department, Dept. Of Anatomy, Saveetha Medical college, Saveetha University Chennai. India
  • Dr. Rvsns. Ramachandrudu Associate Professor, Dept. Of pharmacology, Govt. Medical College. Anantapur AP India
  • Dr. Vijayaraghavan Director, Dept. of Research, Saveetha University, Chennai India
  • Dr. P. Priya Tutor, KMCH Institute of Health Sciences and Research, Coimbatore-641015. Tamilnadu. India

DOI:

https://doi.org/10.22376/ijlpr.2023.13.1.L50-55

Keywords:

Achyranthesaspera, HEAA, Lipid profile, HBA1C, HOMA- IR, Diabetes mellitus, Rats

Abstract

Achyranthes aspera is an herb found in the Indian subcontinent and has been used for decades because of its traditional anti-diabetic and antiobesity properties. Since studies are not reported on Achyranthes aspera protection in high-fat diet and diabetes-induced animal models, our aim was to investigate the protective effect of root extract of Achyranthesaspera on the combined effect of high-fat diet and streptozotocin-induced biochemical changes in Wistar rats. To achieve this aim, the objectives of the study were to estimate the body weight, serum glucose, insulin, Glycated hemoglobin(HbA1c), Homeostatic Model Assessment of Insulin Resistance (HOMA- IR), serum lipid profile, and liver glycogen among the Wistar rats which were divided into 6 groups having 6 rats in each group. Group 1 - control rats Group 2 - diabetic group rats, Group 3 – HFD diabetic rats and the rats from groups 4 to 6 were given a high-fat diet+ Streptozotocin 40 mg/kg + a low dose of root extract of Achyranthes aspera (250 mg/kg), high dose of root extract of Achyranthe saspera (500 mg/kg), metformin (250 mg/kg), respectively treated for 35 days. Body weight followed by serum glucose, insulin, HBA1C, HOMA- IR, serum lipid profile, and liver glycogen were evaluated. HFD + Diabetic group showed an elevated level of lipid profile and alterations in serum glucose, HbA1C, HOMAIR, Insulin and liver glycogen. Administration of Metformin and hydro alcoholic root extract of Achyranthes aspera500 mg/kg to HFD + diabetic group protected the biochemical alterations and serum insulin, glucose levels, HbA1c, HOMA- IR, liver glycogen. In comparison with HFD group, there was 1.76,2.02, and,1.3-fold decrease in Glucose levels in HFD+STZ+ Metformin, HFD+STZ+HEAA250, and HFD+STZ+HEAA500 groups respectively. In comparison with HFD group, there was a 1.38,1.15 and,1.59-fold increase in Insulin levels in HFD+STZ+ Metformin, HFD+STZ+HEAA250, and HFD+STZ+HEAA500 groups respectively. The HbA1C levels (mean±SEM) of control, STZ, HFD+STZ, HFD+STZ+ Metformin, HFD+STZ+HEAA250, and HFD+STZ+HEAA500 were 7.36±0.22,10.18±0.74,8.94±0.33,8.10±0.22,8.94±0.22 and 7.0±0.41 respectively. The HOMA-IR levels (mean±SEM) of control, STZ, HFD+STZ, HFD+STZ+ Metformin, HFD+STZ+HEAA250, andHFD+STZ+HEAA500were 2.08±0.12,3.99±0.85,17.05±3.53,1.61±0.28,2.46±0.74 and 2.01±0.20 respectively The study findings reveal the protective role of Achyranthesaspera on high-fat diet and a diabetic induced biochemical changes.

References

Kaul K, Tarr JM, Ahmad SI, Kohner EM, Chibber R. Introduction to diabetes mellitus. AdvExp Med Biol. 2012;771:1-. doi: 10.1007/978-1-4614-5441-0_1, PMID 23393665.

Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016 Jun 1;37(3):278-316. doi: 10.1210/er.2015-1137, PMID 27159875.

Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2011;8(4):228-36. doi: 10.1038/nrendo.2011.183, PMID 22064493.

Unnikrishnan R, Anjana RM, Mohan V. Diabetes mellitus and its complications in India. Nat Rev Endocrinol. 2016 Jun;12(6):357-70. doi: 10.1038/nrendo.2016.53, PMID 27080137.

Strain WD, Paldánius PM. Diabetes, cardiovascular disease and the microcirculation. CardiovascDiabetol. 2018 Dec;17(1):57. doi: 10.1186/s12933-018-0703-2, PMID 29669543.

Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabet Med. 2005 Apr;22(4):359-70. doi: 10.1111/j.1464-5491.2005.01499.x, PMID 15787657.

Saw M, Wong VW, Ho IV, Liew G. New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy. Eye (Lond). 2019 Dec;33(12):1842-51. doi: 10.1038/s41433-019-0494-z, PMID 31227789.

Kumar A, Gnananath K, Gande S, Goud E, Rajesh P, Nagarjuna S. Antidiabetic Activity of ethanolic Extract of Achyranthesaspera Leaves in streptozotocin induced diabetic rats. J Pharm Res. 2011 Jul;4(7):3124-5.

Meiattini F, Prencipe L, Bardelli F, Giannini G, Tarli P. The 4-hydroxybenzoate/4-aminophenazone chromogenic system used in the enzymic determination of serum cholesterol. Clin Chem. 1978;24(12):2161-5. doi: 10.1093/clinchem/24.12.2161, PMID 719864.

Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19(5):476-82. doi: 10.1093/clinchem/19.5.476, PMID 4703655.

Isezaki M, Shirahata K, Seto H et al. Inst. Reag. Clin Lab. 1996;19:349-53.

Saisho Y. Metformin and inflammation: its potential beyond glucose-lowering effect. Endocrine, Metabolic & Immune disorders-drug Targets (formerly current drug targets-immune, endocrine & metabolic disorders). 2015 Sep 1;15(3):196-205.

Lalau JD. Lactic acidosis induced by metformin: incidence, management and prevention. Drug Saf. 2010 Sep;33(9):727-40. doi: 10.2165/11536790-000000000-00000, PMID 20701406.

Husain N, Kumar A. Phytochemical analysis of flower, leaf and root of Achyranthesaspera from Durg District of Chhattisgarh—a comparative study. Int J Sci Res. 2016;5(3):162246.

Vidhya R, Gandhi GR, Jothi G, Radhika J, Brindha P. Evaluation of antidiabetic potential of Achyranthesaspera Linn. onalloxan induced diabetic animals. Int J Pharm Pharm Sci. 2012;4(5):577-80.

Njideka BE, Theophilus AE, Ugochukwu NT. Use of Achyranthesaspera Linn tea as antidiabetic and hypolipidemic herbal tea. Int J Health Sci Res. 2019;9(2).

Latha BP, Vijaya T, Reddy RM, Ismail M, Rao SD. Therapeutic efficacy of Achyranthesasperasaponin extract in high fat diet induced hyperlipidaemia in male Wistar rats. Afr J Biotechnol. 2011;10(74):17038-42.

Une HD, Deshpande TC. Antihyperglycemic activity of Achyranthesasperalinn. leaves extract by modulation of β-cell functioning in streptozotocin-induced diabetic rats. Phcog Mag. 2021 Jan 1;17(5):15. doi: 10.4103/pm.pm_296_20.

Jiang S, Du P, An L, Yuan G, Sun Z. Anti-diabetic effect of CoptisChinensis polysaccharide in high-fat diet with STZ-induced diabetic mice. Int J BiolMacromol. 2013 Apr 1;55:118-22. doi: 10.1016/j.ijbiomac.2012.12.035, PMID 23295205.

El-Desoky GE, Aboul-Soud MA, Al-Numair KS. Antidiabetic and hypolipidemic effects of Ceylon cinnamon (Cinnamomumverum) in alloxan-diabetic rats. J Med Plants Res. 2012 Mar 9;6(9):1685-91.

Ahmed A, Asad MJ, Ahmad MS, Qureshi R, Shah SI, Gul H et al. Antidiabetic and hypolipidemic potential of RhazyastrictaDecne extract and its fractions. IntCurr Pharm J. 2015 Jan 7;4(2):353-61. doi: 10.3329/icpj.v4i2.21484.

Abtahi-Evari SH, Shokoohi M, Abbasi A, Rajabzade A, Shoorei H, Kalarestaghi H. Protective effect of Galegaofficinalis extract on streptozotocin-induced kidney damage and biochemical factor in diabetic rats. Crescent J Med Biol Sci. 2017;4:108-14.

Li F, Tang H, Xiao F, Gong J, Peng Y, Meng X. Protective effect of salidroside from Rhodiolae Radix on diabetes-induced oxidative stress in mice. Molecules. 2011 Dec 1;16(12):9912-24. doi: 10.3390/molecules16129912, PMID 22134398.

Abhaykumar K. Phytochemical studies on Achyranthesaspera. World Sci News. 2018;100:16-34.

Edwin S, Jarald EE, Deb L, Jain A, Kinger H, Dutt KR et al. Wound healing and antioxidant activity of Achyranthesaspera. Pharm Biol. 2008 Jan 1;46(12):824-8. doi: 10.1080/13880200802366645.

Husain N, Kumar A. Phytochemical analysis of flower, leaf and root of Achyranthesaspera from Durg District of Chhattisgarh—a comparative study. Int J Sci Res. 2016;5(3):162246.

Khan N, Akhtar MS, Khan BA, Braga Vde A, Reich A. Antiobesity, hypolipidemic, antioxidant and hepatoprotective effects of Achyranthesasperaseedsaponins in high cholesterol fed albino rats. Arch Med Sci. 2015 Dec 11;11(6):1261-71. doi: 10.5114/aoms.2015.56353, PMID 26788089.

Krishnakumari S, Priya K. Hypolipidemic efficacy of Achyranthesaspera on lipid profile in sesame oil fed rats. AncSci Life. 2006 Jan;25(3-4):49.

Vijaya Kumar S, Sankar P, Varatharajan R. Anti-inflammatory activity of roots of Achyranthesaspera. Pharm Biol. 2009 Oct 1;47(10):973-5. doi: 10.1080/13880200902967979.

Published

2022-11-18

How to Cite

Shahajeer, B. ., Raghunathn, D. G. ., Ramachandrudu, D. R., Vijayaraghavan, D. ., & Priya, D. P. (2022). Achyranthes Aspera Root Extract Attenuates the Damage Caused by High Fat Diet and Streptozotocin-Induced Diabetes in Wistar Rats: Life Sciences -Anatomy. International Journal of Life Science and Pharma Research, 13(1), L50-L55. https://doi.org/10.22376/ijlpr.2023.13.1.L50-55

Issue

Section

Research Articles